Astellas Pharma FY21 Core Profit Decreases; Revenue Up 3.7%

Astellas Pharma Inc. (ALPMY,ALPMY) reported that its fiscal 2021 core operating profit decreased by 2.6% year-on-year to 244.7 billion yen, and core profit decreased by 9.2% to 190.6 billion yen. Basic core earnings per share was 103.03 yen compared to 113.03 yen.

Fiscal 2021 profit to owners of parent increased to 124.09 billion yen from 120.59 billion yen. Earnings per share was 67.05 yen compared to 64.90 yen. Fiscal year 2021 revenue increased by 3.7% to 1.30 trillion yen.

For fiscal 2022, the company projects: basic core earnings per share of 122.05 yen; and revenue of 1.44 trillion yen.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Nestle Purina PetCare Co. has recalled a limited amount of certain prescription wet dog food citing labeling error, the U.S. Food and Drug Administration said. The recall involves Purina Pro Plan Veterinary Diets EN Gastroenteric Low Fat or PPVD EN Low Fat wet dog food that comes in 13.4 oz cans. Exportadora Copramar is recalling 1260 cases of James Farm frozen raspberries citing potential to be contaminated with Hepatitis A, the U.S. Food and Drug Administration said. The recall involves James Farm branded frozen raspberries identified by UPC Code: 76069501010 and Lot Code - 22-165. American Honda Motor Co, Inc. has recalled about 2,900 units of 2022 model year Honda TRX90X All-Terrain Vehicles (ATVs) sold in the United States for possible crash and injury hazard, according to a statement issued by the U.S. Consumer Product Safety Commission or CPSC.
Follow RTT